NDC 63629-9263-01 - Sodium Sulfacetamide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63629-9263
Requested NDC
63629-9263-01
Package NDCs from labels
63629-9263-1, 63629-9263-01
Manufacturer
Bryant Ranch Prepack
Effective date
2026-04-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Sodium Sulfacetamide - Bryant Ranch PrepackBryant Ranch Prepack2026-04-24HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-9263-1Sodium Sulfacetamide355 g in 1 BOTTLELIQUID355103

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-9263SODIUM SULFACETAMIDE LIQUID [BRYANT RANCH PREPACK]102Current NDC, Legacy NDC, 1 package rows20240511_c9f90612-32c6-44ba-85d5-82842f0e1ba9.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-9263-1GM - Gram63629-926322d67659-abe4-4504-9c93-b465de7dc85012022-06-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 32 · 631 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SODIUM SULFACETAMIDE, SULFURSODIUM SULFACETAMIDE 8% SULFUR 4%Aspen Medical LLC4ba94e96-b107-77fe-e063-6394a90aa9802026-02-21Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
WowDay Hemorrhoid and Fissure CreamHEMORRHOID AND FISSURE CREAMWowDay LLC47ba86ad-240a-e733-e063-6394a90a24e32026-02-12WarningsExact identifier
unii: PDC6A3C0OX
Sodium SulfacetamideSODIUM SULFACETAMIDEMethod Pharmaceuticals, LLCd65e777b-682b-732d-e053-2a95a90a41ad2026-02-12WarningsExact identifier
ndc (product): 58657-477
rxcui: 1006107
spl id: 4aad445c-77e0-b8cd-e063-6394a90afd06
spl set id: d65e777b-682b-732d-e053-2a95a90a41ad
unii: 4NRT660KJQ
Sodium Sulfacetamide and SulfurSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticals, LLCd35a7764-f3c6-fd1b-e053-2a95a90a80362026-02-12WarningsExact identifier
unii: 4NRT660KJQ
Sodium Sulfacetamide 9% and Sulfur 4% CleanserSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticalsd770b9e2-dbbe-c246-e053-2995a90a398d2026-02-12Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
Sodium Sulfacetamide 9% and Sulfur 4.5% CleanserSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticalsd770860b-ecbd-ba22-e053-2a95a90af6912026-02-12Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
Sodium Sulfacetamide 8% and Sulfur 4% CleanserSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticalsd8dcbf63-58f0-0a25-e053-2a95a90a76332026-02-12Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
Sodium Sulfacetamide 10% and Sulfur 2% CleanserSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticalsd736fbd6-4cff-bc33-e053-2a95a90a26fd2026-02-12Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient CreamSODIUM SULFACETAMIDE 10% AND SULFUR 5% EMOLLIENT CREAMMethod Pharmaceuticals, LLCdfc5bab2-2170-606e-e053-2a95a90a39612026-02-12Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
sulfacetamide sodium and sulfur Sodium Sulfacetamide - SulfurSULFACETAMIDE SODIUM AND SULFURAllegis Pharmaceuticals, LLC1aa1025f-c568-34d3-e063-6394a90a37b82026-02-11Warnings, Adverse reactionsExact identifier
unii: 4NRT660KJQ
Viva Hydration BoostGLYCERINNomax Inc174193b2-65eb-b5fd-e063-6394a90a9cd02026-02-10WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc376e0289-28e9-e87f-e063-6294a90a3b042026-01-30WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc10c3e31d-779d-8ff6-e063-6294a90acd392026-01-30WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc9e96976b-2990-79e0-e053-2995a90a0f292026-01-30WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Incd81c1a4f-87b0-ee8c-e053-2995a90af9e52026-01-30WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Incf452a2c4-c869-7bf5-e053-2995a90ac1a02026-01-30WarningsExact identifier
unii: PDC6A3C0OX
Additive Formula 3DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINETerumo BCT, Ltd9a5247a1-cc05-442d-b2d0-950f887f03c22026-01-30Warnings, Adverse reactionsExact identifier
unii: 2968PHW8QP
Regener-Eyes Ophthalmic Solution LITE XLGLYCERIN OPHTHALMIC SOLUTIONM & M PRODUCTS, L.L.C.47ab9609-4291-30b2-e063-6394a90a421e2026-01-29WarningsExact identifier
unii: PDC6A3C0OX
Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XLGLYCERIN OPHTHALMIC SOLUTIONM & M PRODUCTS, L.L.C.48d6dc98-66e8-b499-e063-6394a90ae9352026-01-29WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc86c14327-ffc7-806e-e053-2991aa0aaf922026-01-29WarningsExact identifier
unii: PDC6A3C0OX

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.